Subcutaneous depot medroxyprogesterone acetate (DMPA-SC), also known as Sayana Press, is an all-in-one injectable that can be administered by paraprofessionals or even clients themselves. Dozens of countries are exploring the benefits of adding this new easy-to-use contraception to the mix of currently available family planning methods. HP+ developed the DMPA-SC Impact Model to help project the benefits over five years that could come from the introduction of DMPA-SC, in terms of effects on contraceptive prevalence rate, increased access to family planning through public and private service delivery points, and costs to the health care system and clients.
Rosen, J., M. Weinberger, and E. McGinn. 2018. “Model for DMPA-SC Impact.” Washington, DC: Palladium, Health Policy Plus.
English XLSX 6253.7 kbNovember 2018
Rosen, J., M. Weinberger, and E. McGinn. 2018. Modeling the Health and Cost Impacts of DMPA-SC Introduction and Scale-Up: Manual for Using the Model for DMPA-SC Impact. Washington, DC: Palladium, Health Policy Plus.
English PDF 1518.2 kbNovember 2018
Information presented on this website is considered public information and may be distributed or copied freely unless identified as being subject to copyright protection.